Stock comparison
Revolution Medicines, Inc. is 26.3x more valuable than NOVAVAX INC by market capitalization ($40.63 B vs $1.55 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
RVMD is larger
Revolution Medicines, Inc. is 26.3x more valuable than NOVAVAX INC by market capitalization ($40.63 B vs $1.55 B).
Market value leader
RVMD
Revolution Medicines, Inc. is 26.3x more valuable than NOVAVAX INC by market capitalization ($40.63 B vs $1.55 B).
Revenue leader
NVAX
NVAX: $1.12B vs RVMD: $0.00.
Profit leader
NVAX
NVAX: $440.30M vs RVMD: -$1.13B.
| Metric | NVAX | RVMD |
|---|---|---|
| Market cap | $1.55 B | $40.63 B |
| US-listed rank | #2337 | #384 |
| Revenue (latest FY) | $1.12B | $0.00 |
| Net income (latest FY) | $440.30M | -$1.13B |
| Net margin | 39.2% | - |
| P/E (trailing FY) | 3.5x | - |
| SEC filings | 1,627 | 777 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Revolution Medicines, Inc. is 26.3x more valuable than NOVAVAX INC by market capitalization ($40.63 B vs $1.55 B).
In their latest fiscal years, NOVAVAX INC reported $1.12B in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: NOVAVAX INC and Revolution Medicines, Inc., or browse the full rankings.